Clinical Challenges: First-Line Options for Metastatic RCC
Fifteen years ago, the average patient who walked into an oncology clinic with metastatic renal…
Browsing Tag
Nivolumab
Neoadjuvant Nivolumab a ‘New Standard’ in Lung Cancer
NEW ORLEANS -- The addition of the immune checkpoint inhibitor nivolumab (Opdivo) to neoadjuvant chemotherapy substantially improved…
Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in…
SAN DIEGO and SUZHOU, China, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) today announced that the first patients have been dosed in a phase 1b/2 clinical…
Relatlimab With Nivolumab Improves Progression-free Survival in Melanoma
The benefit of the combination therapy was observed across pre-specified subgroups. The Food and Drug Administration granted priority review to the combination in September 2021 based on…
Nivolumab + Ipilimumab Have an Added Benefit in Mesothelioma
The effect depends on a subgroup characteristic, i.e. "tumour histology": For patients with non-epithelioid mesothelioma, there is an indication of considerable added benefit compared to…